UNH
48
3
GILD
63
-12
TJX
48
11
NAVI
30
6
FTI
66
13
KMI
77
4
MMM
57
5
QRVO
9
5
FCX
47
4
APA
34
2
HIG
78
6
NTRS
52
7
ZION
55
7
HON
58
3
TDC
34
3
MS
53
5
CLX
68
2
DHR
51
6
ZBH
65
3
EMR
57
3
UNH
48
3
GILD
63
-12
TJX
48
11
NAVI
30
6
FTI
66
13
KMI
77
4
MMM
57
5
QRVO
9
5
FCX
47
4
APA
34
2
HIG
78
6
NTRS
52
7
ZION
55
7
HON
58
3
TDC
34
3
MS
53
5
CLX
68
2
DHR
51
6
ZBH
65
3
EMR
57
3
Financhill
Back

Puma Biotechnology 10K Form

Sell
49

PBYI
Puma Biotechnology

Last Price:
$3.32
Seasonality Move:
-5.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PBYI News And Ratings

See the #1 stock for the next 7 days that we like better than PBYI

PBYI Financial Statistics

Sales & Book Value

Annual Sales: $230.5M
Cash Flow: $15.6M
Price / Cash Flow: 4.16
Annual Sales: $1.88
Price / Book: 1.79

Profitability

EPS (TTM): 0.61000
Net Income (TTM): $30.3M
Gross Margin: $166.1M
Return on Equity: 47.89%
Return on Assets: 13.97%

Puma Biotechnology Earnings Forecast

Key Puma Biotechnology Financial Ratios

  • The Gross Profit Margin over the past 17 years for PBYI is 72.06%.
  • The Selling, General & Administrative Expenses for PBYI have been equal to 35.01% of Gross Profit Margin.
  • The Research & Development expenses have been 23.84% of Revenue.
  • The Interest Expense is 41.13% of Operating Income.
  • The Net Earning history of PBYI is 13.14% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 10 years.

Puma Biotechnology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PBYI
CUSIP: 74587V
Website: pumabiotechnology.com

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 1.54
Quick Ratio: 1.38

Price-to-Earnings

Trailing P/E Ratio: 5.35
Forward P/E Ratio: 5.77

PBYI Technical Analysis vs Fundamental Analysis

Sell
49
Puma Biotechnology (PBYI) is a Sell

Is Puma Biotechnology a Buy or a Sell?